Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Issuer Symbol
-
ESPR on Nasdaq
Benjamin Halladay - trading volume in the past year for Esperion Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
467,525 |
$1,714,414 |
$3.67 |
17 Dec 2025 |
Direct |
|
|
| Stock Option (right to buy) |
213,000 |
$345,060 |
$1.62 |
14 Mar 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.